Storebrand Asset Management As
Source: SEC Form 13F · as of Mar 2026Storebrand Asset Management As holds 11 biotech & pharma companies tracked by BioSniper, totaling $231.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$231.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 952,156 | $132.7M |
| REGNREGENERON PHARMACEUTICALS, INC. | 35,939 | $27.8M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 64,595 | $21.4M |
| JAZZJazz Pharmaceuticals plc | 109,134 | $20.6M |
| INSMINSMED Inc | 90,826 | $14.9M |
| INCYIncyte Corp. | 80,755 | $7.6M |
| RVMDREVOLUTION MEDICINES, INC. | 53,365 | $5.2M |
| ONCBeOne Medicines Ltd. | 4,668 | $1.4M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 1,791 | $101K |
| OGNOrganon & Co. | 9,785 | $59K |
| HCMHUTCHMED (China) Limited | 1,219 | $18K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.